Bonjour, new guests from small-town India
Puneet Dhawan of Accor is brimming with ideas on ways to revive the hospitality sector
A team of researchers found in a randomised controlled trial that umbilical cord-derived mesenchymal stem cell (UC-MSC) infusions safely reduce the risk of death and quicken time to recovery for the most severe Covid-19 patients.
The study, published in the journal STEM CELLS, was carried out by Camilo Ricordi, Director of the Diabetes Research Institute (DRI) and Cell Transplant Center at the University of Miami Miller School of Medicine, and his team of international collaborators.
The study analyzed 24 patients hospitalised at the University of Miami Tower or Jackson Memorial Hospital with Covid-19. Each patient received two infusions of either mesenchymal stem cells or a placebo, given days apart.
Lead author Ricordi said: “It was a double-blind study. Neither the doctors nor patients knew who received the treatment and who got the placebo.”
At one month, 100 per cent of patients (<85 of age) who received the UC-MSC infusions survived as compared with 42 per cent in the control group. Researchers found the treatment was safe, with no infusion-related serious adverse events.
Ricordi’s team also reports recovery time was faster among those in the treatment arm. More than half of the patients treated with the UC-MSC infusions recovered and were discharged within two weeks. More than 80 per cent of the treatment group recovered by day 30 as compared with less than 37 per cent in the control group.
“It’s like smart bomb technology in the lungs to restore normal immune response and reverse life-threatening complications,” said Ricordi.
Just one umbilical cord, donated from a cesarean section, can yield up to 10,000 doses of the Covid-19 treatment.
“Our results confirm the powerful anti-inflammatory, the immunomodulatory effect of UC-MSCs. These cells have clearly inhibited the ‘cytokine storm’, a hallmark of severe Covid-19,” said Giacomo Lanzoni, PhD, another author of the paper.
Puneet Dhawan of Accor is brimming with ideas on ways to revive the hospitality sector
Citroen’s first vehicle sports a novel design and European interiors. It is also meant to be as comfortable as ...
The pandemic is only the tip of the iceberg that the country’s cash-poor airlines — both regional and national ...
The government is yet to specify the framework of its recently announced old vehicle scrappage policy
This Women’s Day, we discuss the features of a few financial products that aim to help you save, get insured ...
Sensex, Nifty 50 make a strong bounce-back, but test resistances
Avenue Supermarts (₹3,286.1): Makes fresh all-time highIn October last year, the stock of Avenue Supermarts ...
The exchange-traded fund ticks all boxes as an efficient tool to track gold prices
Muriel has put our names down on a list to get the Covid-19 vaccination because — hurrah! — the age limit has ...
They are the health warriors who battled the Covid-19 pandemic on the ground, and are now the face of the ...
Uzbekistan’s grandest city dazzles tourists with its history, architecture and food
It’s the birth anniversary of Michelangelo di Lodovico Buonarroti Simoni, one of the great artists and ...
Comfort, convenience, value, safety — and not necessarily the colour pink — but do brands deliver?
Why and how marketers have used camels, and left us thirsting for more
Start-up SALT wants to break feminine stereotypes around money, and is asking women to reassert agency
It’s that time of year again when brands suddenly start paying obeisance to women power. From sentimental to ...
Three years after its inception, compliance with GST procedures remains a headache for exporters, job workers ...
Corporate social responsibility (CSR) initiatives of companies are altering the prospects for wooden toys of ...
Aequs Aerospace to create space for large-scale manufacture of toys at Koppal
And it has every reason to smile. Covid-19 has triggered a consumer shift towards branded products as ...
Please Email the Editor